EBITDA Summary of AptarGroup, Inc.

AptarGroup, Inc.'s latest annual EBITDA in 2023 was 663.83 Million USD , up 14.48% from previous year.
AptarGroup, Inc.'s latest quarterly EBITDA in 2024 Q2 was 196.69 Million USD , up 8.07% from previous quarter.
AptarGroup, Inc. reported an annual EBITDA of 609.4 Million USD in 2022, up 2.09% from previous year.
AptarGroup, Inc. reported an annual EBITDA of 586.79 Million USD in 2021, up 4.15% from previous year.
AptarGroup, Inc. reported a quarterly EBITDA of 179.91 Million USD for 2024 Q1, up 14.99% from previous quarter.
AptarGroup, Inc. reported a quarterly EBITDA of 196.69 Million USD for 2024 Q2, up 8.07% from previous quarter.

Annual EBITDA Chart of AptarGroup, Inc. (2023 - 1992)

Historical Annual EBITDA of AptarGroup, Inc. (2023 - 1992)

Year	EBITDA	EBITDA Growth
2023	663.83 Million USD	14.48%
2022	609.4 Million USD	2.09%
2021	586.79 Million USD	4.15%
2020	556.17 Million USD	-1.92%
2019	576.91 Million USD	10.92%
2018	475.56 Million USD	8.86%
2017	490.08 Million USD	4.29%
2016	470.49 Million USD	0.52%
2015	468.04 Million USD	1.86%
2014	459.51 Million USD	2.89%
2013	446.65 Million USD	11.54%
2012	397.34 Million USD	-6.22%
2011	426.48 Million USD	5.6%
2010	401.71 Million USD	20.73%
2009	333.55 Million USD	-9.68%
2008	370.8 Million USD	10.73%
2007	342.92 Million USD	20.82%
2006	276.2 Million USD	10.99%
2005	249.03 Million USD	6.6%
2004	235.37 Million USD	10.11%
2003	209.79 Million USD	14.95%
2002	179.21 Million USD	1.7%
2001	175.45 Million USD	-0.45%
2000	184.83 Million USD	1.28%
1999	177.13 Million USD	30.14%
1998	149.6 Million USD	12.13%
1997	128.9 Million USD	13.49%
1996	111.8 Million USD	10.55%
1995	102.9 Million USD	16.82%
1994	87.1 Million USD	23.21%
1993	73.2 Million USD	19.34%
1992	62.1 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	210.43 Million USD	8.88%
2024 Q1	179.91 Million USD	14.99%
2024 Q2	196.69 Million USD	8.07%
2023 Q4	181.33 Million USD	-4.62%
2023 FY	- USD	14.48%
2023 Q1	154.09 Million USD	4.56%
2023 Q2	181.88 Million USD	18.04%
2023 Q3	190.12 Million USD	4.53%
2022 Q1	155.76 Million USD	1.01%
2022 Q2	160.91 Million USD	3.31%
2022 FY	- USD	2.09%
2022 Q4	147.37 Million USD	-4.24%
2022 Q3	153.89 Million USD	-4.36%
2021 Q3	152.76 Million USD	4.82%
2021 FY	- USD	4.15%
2021 Q1	152.6 Million USD	2.16%
2021 Q2	145.74 Million USD	-4.49%
2021 Q4	154.2 Million USD	0.94%
2020 FY	- USD	-1.92%
2020 Q1	142.06 Million USD	9.72%
2020 Q2	133.16 Million USD	-6.27%
2020 Q3	156.58 Million USD	17.59%
2020 Q4	149.37 Million USD	-4.6%
2019 Q4	129.48 Million USD	-11.56%
2019 Q3	146.4 Million USD	-8.76%
2019 Q2	160.46 Million USD	2.71%
2019 Q1	156.23 Million USD	19.01%
2019 FY	- USD	10.92%
2018 Q4	131.27 Million USD	4.7%
2018 FY	- USD	8.86%
2018 Q3	125.38 Million USD	-11.19%
2018 Q2	141.17 Million USD	3.52%
2018 Q1	136.38 Million USD	3.48%
2017 Q1	115.07 Million USD	5.73%
2017 FY	- USD	4.29%
2017 Q2	124.52 Million USD	8.21%
2017 Q3	119.33 Million USD	-4.16%
2017 Q4	131.79 Million USD	10.44%
2016 Q4	108.84 Million USD	-11.81%
2016 FY	- USD	0.52%
2016 Q1	104.32 Million USD	-1.71%
2016 Q2	133.95 Million USD	28.4%
2016 Q3	123.42 Million USD	-7.86%
2015 Q1	109.05 Million USD	6.17%
2015 FY	- USD	1.86%
2015 Q4	106.14 Million USD	-14.24%
2015 Q3	123.76 Million USD	-4.14%
2015 Q2	129.11 Million USD	18.39%
2014 Q2	123.41 Million USD	6.57%
2014 Q1	115.8 Million USD	8.71%
2014 FY	- USD	2.89%
2014 Q4	102.71 Million USD	-12.66%
2014 Q3	117.6 Million USD	-4.71%
2013 Q2	122.83 Million USD	17.3%
2013 Q1	104.72 Million USD	11.01%
2013 Q3	112.56 Million USD	-8.36%
2013 FY	- USD	11.54%
2013 Q4	106.52 Million USD	-5.37%
2012 FY	- USD	-6.22%
2012 Q1	103.95 Million USD	8.42%
2012 Q2	100.28 Million USD	-3.53%
2012 Q3	102.24 Million USD	1.95%
2012 Q4	94.33 Million USD	-7.73%
2011 Q3	109.46 Million USD	-6.2%
2011 Q1	96.38 Million USD	0.15%
2011 FY	- USD	5.6%
2011 Q4	95.88 Million USD	-12.4%
2011 Q2	116.7 Million USD	21.08%
2010 Q2	107.04 Million USD	11.06%
2010 Q1	96.38 Million USD	-1.55%
2010 Q3	104.66 Million USD	-2.22%
2010 Q4	96.23 Million USD	-8.06%
2010 FY	- USD	20.73%
2009 Q3	86.6 Million USD	4.05%
2009 FY	- USD	-9.68%
2009 Q4	97.89 Million USD	13.05%
2009 Q1	70.68 Million USD	-23.77%
2009 Q2	83.23 Million USD	17.75%
2008 Q2	99.33 Million USD	12.12%
2008 Q4	92.72 Million USD	0.43%
2008 Q3	92.33 Million USD	-7.04%
2008 Q1	88.59 Million USD	11.37%
2008 FY	- USD	10.73%
2007 Q2	89.29 Million USD	17.12%
2007 Q1	76.24 Million USD	6.35%
2007 FY	- USD	20.82%
2007 Q4	79.55 Million USD	-11.4%
2007 Q3	89.78 Million USD	0.55%
2006 Q3	73.2 Million USD	1.05%
2006 Q4	71.69 Million USD	-2.06%
2006 Q2	72.44 Million USD	21.09%
2006 Q1	59.82 Million USD	5.17%
2006 FY	- USD	10.99%
2005 Q2	66.94 Million USD	11.23%
2005 FY	- USD	6.6%
2005 Q1	60.18 Million USD	-0.15%
2005 Q4	56.88 Million USD	-13.42%
2005 Q3	65.7 Million USD	-1.85%
2004 Q4	60.27 Million USD	1.46%
2004 Q1	55.34 Million USD	5.7%
2004 FY	- USD	10.11%
2004 Q2	59.23 Million USD	7.04%
2004 Q3	59.41 Million USD	0.29%
2003 Q2	54.95 Million USD	7.42%
2003 Q3	53.16 Million USD	-0.01%
2003 Q4	51.82 Million USD	-4.33%
2003 FY	- USD	14.95%
2003 Q1	51.11 Million USD	11.04%
2002 Q2	45.7 Million USD	7.43%
2002 Q4	45.74 Million USD	-4.99%
2002 Q3	48.07 Million USD	2.58%
2002 Q1	39.68 Million USD	23.82%
2002 FY	- USD	1.7%
2001 Q2	43.53 Million USD	-0.78%
2001 Q3	45.99 Million USD	-7.19%
2001 Q4	35.94 Million USD	-24.1%
2001 FY	- USD	-0.45%
2001 Q1	49.97 Million USD	19.98%
2000 Q2	49.38 Million USD	5.05%
2000 Q4	41.64 Million USD	-7.29%
2000 FY	- USD	1.28%
2000 Q1	46.97 Million USD	5.14%
2000 Q3	46.84 Million USD	-6.53%
1999 Q3	46.5 Million USD	11.09%
1999 FY	- USD	30.14%
1999 Q1	41.2 Million USD	56.54%
1999 Q2	45.6 Million USD	10.81%
1999 Q4	43.9 Million USD	-11.98%
1998 FY	- USD	12.13%
1998 Q4	35.5 Million USD	-35.96%
1998 Q3	40 Million USD	9.14%
1998 Q2	38.1 Million USD	6.59%
1998 Q1	36 Million USD	19.52%
1997 Q2	33.1 Million USD	3.54%
1997 Q1	31.8 Million USD	13.92%
1997 FY	- USD	13.49%
1997 Q4	31.7 Million USD	-5.81%
1997 Q3	32.2 Million USD	-3.73%
1996 FY	- USD	10.55%
1996 Q2	26.9 Million USD	-7.83%
1996 Q4	27.2 Million USD	-1.44%
1996 Q3	28.3 Million USD	6.95%
1996 Q1	29.3 Million USD	22.71%
1995 Q1	26.2 Million USD	23.27%
1995 Q2	26.8 Million USD	4.02%
1995 Q3	25.6 Million USD	-4.25%
1995 Q4	24.2 Million USD	-7.66%
1995 FY	- USD	16.82%
1994 Q3	21.2 Million USD	-7.73%
1994 Q1	22.5 Million USD	48.63%
1994 Q2	22.9 Million USD	1.38%
1994 FY	- USD	23.21%
1994 Q4	20.3 Million USD	-0.49%
1993 Q3	19.3 Million USD	-8.25%
1993 Q1	17.4 Million USD	106.97%
1993 Q2	20.3 Million USD	15.48%
1993 Q4	16.3 Million USD	-17.98%
1993 FY	- USD	19.34%
1992 Q2	92.1 Million USD	0.55%
1992 FY	- USD	0.0%
1992 Q1	91.6 Million USD	0.0%
1992 Q3	93.2 Million USD	1.19%
1992 Q4	-240.9 Million USD	-358.48%

Peer EBITDA Comparison of AptarGroup, Inc.

Name	EBITDA	EBITDA Difference
Alcon Inc.	2.39 Billion USD	72.26%
Baxter International Inc.	2.77 Billion USD	76.087%
Becton, Dickinson and Company	2.42 Billion USD	72.625%
Bausch + Lomb Corporation	586 Million USD	-13.283%
Haemonetics Corporation	262.09 Million USD	-153.278%
Envista Holdings Corp	171.1 Million USD	-287.981%
ResMed Inc.	1.6 Billion USD	58.519%
Teleflex Incorporated	792.26 Million USD	16.21%
Warby Parker Inc.	-30.21 Million USD	2297.259%
West Pharmaceutical Services, Inc.	847.8 Million USD	21.699%

Global Stocks Search

AptarGroup, Inc. (ATR)

EBITDA Summary of AptarGroup, Inc.

Annual EBITDA Chart of AptarGroup, Inc. (2023 - 1992)

Historical Annual EBITDA of AptarGroup, Inc. (2023 - 1992)

Peer EBITDA Comparison of AptarGroup, Inc.